Partnership with EntityRisk to provide evidence-based insight into the economic value of Cleo’s Ovarian Cancer Pre-Surgical Test in the U.S.
Latest events and news from across the industry
Pennsylvania Convention Center, Philadelphia, PA
May 17-20, 2026
All Day Event
Join EntityRisk and industry leaders for a discussion on how HEOR and Market Access professionals are navigating the evolving policy, access, and value landscapes.
Come visit us at Booth #805.
Philadelphia, PA
May 20, 2026
11:30 AM - 1:00 PM ET
Darius Lakdawalla, PhD, Co-Founder and Chief Scientific Officer of EntityRisk and Chief Scientific Officer of the USC Schaeffer Center, will participate as a speaker to discuss how U.S. drug policies are reshaping innovation, evidence, and access globally.
Philadelphia, PA
May 19, 2026
1:45 - 2:45 PM ET
Neal Masia, PhD, Co-Founder and CEO of EntityRisk, will speak at this ISPOR Workshop. He will discuss when development-stage biotechs should implement HEOR capabilities and how these teams can maximize an organization's clinical and commercial impact.
Philadelphia, PA
May 18, 2026
12:45 - 1:15 PM ET
Neal Masia, PhD, Co-Founder and CEO of EntityRisk, will speak at this ISPOR Fast Facts Session. This session will examine how shifting global health policies and fragmented regulatory environments are reshaping pharmaceutical R&D, market prioritization, and the consequential effects.
Partnership with EntityRisk to provide evidence-based insight into the economic value of Cleo’s Ovarian Cancer Pre-Surgical Test in the U.S.
Industry leaders attending will see heightened security all around
Establishing a floor price mechanism would protect valuable innovation
Medicare agency releases hundreds of pages of data, other info